No Data
No Data
Analysts Offer Insights on Materials Companies: Alumis Inc. (ALMS) and Martin Marietta Materials (MLM)
Alumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Oppenheimer Maintains Alumis(ALMS.US) With Buy Rating, Cuts Target Price to $26
Oppenheimer Reaffirms Their Buy Rating on Alumis Inc. (ALMS)
Alumis Price Target Lowered to $26 From $32 at Oppenheimer
Alumis And ACELYRIN's Merger Marks A New Era For Late-Stage Biopharma Advancements
HannChau : I will not be silent stalker but always will be voice out 'stalker'![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Best Yavo : can I ask what time frames do u look at when trading?
Jaguar8 OP Best Yavo : 1,3,5,15 for active trades
Best Yavo : thank you
MilaDing Best Yavo : When do you usually release Watchlist information?
View more comments...